2.2 Combination possibilities
This product can be combined with the following Ottobock components:
Power supply (rechargeable battery)
•
757B35=1 / 757B35=3 / 757B35=5 MyoEnergy Integral
•
757B20/757B21 EnergyPack
Battery chargers
The following battery chargers can be used depending on the rechargeable battery:
•
757L20 charger (including 757L16* power supply)
•
757L35 battery charger
Lamination rings
•
10S1=* lamination ring (for 8E38=*, 8E43=*)
•
9S110=* lamination ring (for 8E39=*)
Active rotation
•
10S17 electric wrist rotator
•
13E205 MyoRotronic
Passive rotation
•
9E169 coaxial plug
•
10S4 coupling piece
Elbow
•
ErgoArm Hybrid plus: 12K44=*
•
ErgoArm Electronic plus: 12K50=*
•
DynamicArm: 12K100N=*/12K110N=*
3 Intended use
3.1 Indications for use
The product is intended exclusively for upper limb exoprosthetic fittings.
3.2 Conditions of use
The product is intended exclusively for use on one user. Use of the product by another person is
not approved by the manufacturer.
The product was developed for everyday use and must not be used for unusual activities. These
unusual activities include, for example, sports which involve excessive strain and/or shocks to the
wrist joint (pushups, downhill racing, mountain biking, ...) or extreme sports (free climbing,
paragliding, etc.). Furthermore, the product should not be used to operate motor vehicles, heavy
equipment (e.g. construction machines), industrial machines or motor-driven equipment.
Permissible ambient conditions are described in the technical data (see page 42).
3.3 Indications
•
Amputation level below-elbow, above-elbow and shoulder disarticulation
•
For unilateral or bilateral amputation
•
Dysmelia of the forearm or upper arm
•
The patient must be able to understand usage and safety messages and put them into prac
tice.
•
The patient must fulfil the physical and mental requirements for perceiving visual/acoustic sig
nals and/or mechanical vibrations.
3.4 Contraindications
•
All conditions which contradict or go beyond the specifications listed in the section on
"Safety" and "Indications for use".
26